Overview

Treatment of Latent Autoimmune Diabetes of the Adult

Status:
Completed

Trial end date:
2018-11-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to clarify whether patients classified as Latent autoimmune diabetes of the adult (LADA) benefit from early treatment with insulin added to per oral treatment and lifestyle measures.

Phase:

N/A

Details

Lead Sponsor:

Norwegian University of Science and Technology

Treatments:

Insulin
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human
Metformin
Repaglinide
Sitagliptin Phosphate